Amundi

Position in PCVX — Vaxcyte, Inc.

CIK 1330387 Paris, I0

Position in PCVX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$581,474

-$171,515 QoQ

Shares Held

10,003

-22.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#190

of 329 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names. PCVX ranks #39 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,546,509	$768,197,412
2	REGN	Regeneron Pharmaceuticals, Inc.	1,013,540	$631,982,729
3	RPRX	Royalty Pharma plc	3,723,864	$208,797,052
4	ALNY	Alnylam Pharmaceuticals, Inc.	617,471	$185,877,294
5	INCY	Incyte Corp	1,181,498	$133,934,612
6	TECH	BIO-TECHNE Corp	1,827,241	$129,094,576
7	MRNA	Moderna, Inc.	888,779	$62,241,193
8	ARGX	Argenx SE	65,122	$60,418,237

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$581,474	10,003	-22.8%	Shares	Defined	2026-08-11
2026-03-31	$752,989	12,958	+154.6%	Shares	Defined	2026-05-18
2025-12-31	$234,852	5,090	-98.5%	Shares	Defined	2026-02-17
2025-03-31	$12,971,012	343,512	-15.6%	Shares	Defined	2025-05-15
2024-12-31	$33,311,124	406,928	-6.4%	Shares	Defined	2025-02-07
2024-09-30	$49,683,681	434,792	-1.7%	Shares	Defined	2024-11-13
2024-06-30	$33,398,676	442,308	+46.3%	Shares	Defined	2024-08-14
2024-03-31	$20,654,005	302,357	-8.3%	Shares	Defined	2024-05-15
2023-12-31	$20,710,686	329,788	-3.8%	Shares	Defined	2024-02-14
2023-09-30	$17,481,653	342,912	+30.6%	Shares	Defined	2023-11-14
2023-06-30	$13,114,293	262,601	+9984.5%	Shares	Defined	2023-08-14
2022-09-30	$62,496	2,604	0.0%	Shares	Defined	2022-11-14
2022-06-30	$56,663	2,604	-55.1%	Shares	Defined	2022-09-02
2021-12-31	$137,863	5,795	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.